DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Emami Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 4:41 am

Emami

Emami Limited has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company has successfully completed the necessary formalities to maintain its depository account, which is essential for holding and transferring its shares electronically.

For investors, this development is a routine administrative update that ensures the company's shares remain eligible for trading on the stock market. It does not reflect any change in the company's financial performance or business operations. The receipt of this certificate is a standard requirement for listed entities to ensure smooth settlement of trades.

Investors should monitor the company's future announcements for any material business updates. This regulatory filing is a non-event and should not trigger any immediate trading decisions based on this information alone.